SNC PHARMACIE GUIGUE THUILLEUR : revenue, balance sheet and financial ratios

SNC PHARMACIE GUIGUE THUILLEUR is a French company founded 26 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in AURIOL (13390), this company of category PME shows in 2018 a revenue of 940 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SNC PHARMACIE GUIGUE THUILLEUR (SIREN 423686195)
Indicator 2024 2023 2022 2021 2020 2018 2017 2016
Revenue N/C N/C N/C N/C N/C 939 929 € 942 009 € 1 000 739 €
Net income 24 460 € -15 002 € 137 493 € 79 027 € 49 138 € 157 449 € -132 180 € 24 575 €
EBITDA N/C N/C N/C N/C N/C 129 470 € 107 632 € 62 053 €
Net margin N/C N/C N/C N/C N/C 16.8% -14.0% 2.5%

Revenue and income statement

In 2024, SNC PHARMACIE GUIGUE THUILLEUR generates positive net income of 24 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 25 k€ -> 24 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

24 460 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 17%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 75%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

16.896%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

74.898%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

11.6%

Solvency indicators evolution
SNC PHARMACIE GUIGUE THUILLEUR

Sector positioning

Debt ratio
16.9 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good -10 pts over 3 years

In 2024, the debt ratio of SNC PHARMACIE GUIGUE THUI... (16.90) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
74.9% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent +13 pts over 3 years

In 2024, the financial autonomy of SNC PHARMACIE GUIGUE THUI... (74.9%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 184.96. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

184.955

Liquidity indicators evolution
SNC PHARMACIE GUIGUE THUILLEUR

Sector positioning

Liquidity ratio
184.96 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good -10 pts over 3 years

In 2024, the liquidity ratio of SNC PHARMACIE GUIGUE THUI... (184.96) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SNC PHARMACIE GUIGUE THUILLEUR

Positioning of SNC PHARMACIE GUIGUE THUILLEUR in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SNC PHARMACIE GUIGUE THUILLEUR is estimated at 341 479 € (range 237 801€ - 510 873€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
237k€ 341k€ 510k€
341 479 € Range: 237 801€ - 510 873€
NAF 5 année 2024

Valuation method used

Net Income Multiple
24 460 € × 14.0x = 341 480 €
Range: 237 801€ - 510 873€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SNC PHARMACIE GUIGUE THUILLEUR with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SNC PHARMACIE GUIGUE THUILLEUR

What is the revenue of SNC PHARMACIE GUIGUE THUILLEUR ?

The revenue of SNC PHARMACIE GUIGUE THUILLEUR in 2018 is 940 k€.

Is SNC PHARMACIE GUIGUE THUILLEUR profitable?

Yes, SNC PHARMACIE GUIGUE THUILLEUR generated a net profit of 24 k€ in 2024.

Where is the headquarters of SNC PHARMACIE GUIGUE THUILLEUR ?

The headquarters of SNC PHARMACIE GUIGUE THUILLEUR is located in AURIOL (13390), in the department Bouches-du-Rhone.

Where to find the tax return of SNC PHARMACIE GUIGUE THUILLEUR ?

The tax return of SNC PHARMACIE GUIGUE THUILLEUR is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SNC PHARMACIE GUIGUE THUILLEUR operate?

SNC PHARMACIE GUIGUE THUILLEUR operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.